17 Jul 2023 15:00
Arix Bioscience PLC (ARIX) Holding(s) in Company 17-Jul-2023 / 15:00 GMT/BST TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BD045071 Issuer Name ARIX BIOSCIENCE PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Ruffer LLP City of registered office (if applicable) London Country of registered office (if applicable) United Kingdom 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached 14-Jul-2023 6. Date on which Issuer notified 17-Jul-2023 7. Total positions of person(s) subject to the notification obligation
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached 8A. Voting rights attached to shares
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
9. Information in relation to the person subject to the notification obligation 1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.
10. In case of proxy voting Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information Ruffer LLP now controls the voting rights over 6,440,000 shares (less than 5% of the voting rights) of Arix Bioscience plc which are held by the discretionary clients of Ruffer LLP and its subsidiaries (the voting of which is all controlled by Ruffer LLP).This change from 5% to less than 5% is due to the sale of 80,000 shares by Ruffer LLP on 14 July 2023. 12. Date of Completion 17-Jul-2023 13. Place Of Completion Ruffer LLP Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ISIN: | GB00BD045071 |
| Category Code: | HOL |
| TIDM: | ARIX |
| LEI Code: | 213800OVT3AHQCXNIX43 |
| OAM Categories: | 2.3. Major shareholding notifications |
| Sequence No.: | 258222 |
| EQS News ID: | 1681769 |
| End of Announcement | EQS News Service |
UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.